Rx Medicare

AcelRx Pharmaceuticals, Inc announced that it has successfully completed an End-of-Phase 2 meeting with the FDA for ARX-01, a drug/device combination product based on the company’s proprietary NanoTab(TM) dosage form, which enables delivery of sufentanil by the non-invasive oral transmucosal (sublingual) route. ARX-01 offers a non-invasive alternative to intravenous patient-controlled analgesia (IV PCA) for the management of acute post-operative pain in the hospital setting.

Read More…

Related Posts

• AcelRx Announces Positive Phase 2 Results From A Study Of ARX-01 Sufentanil NanoTabs In Treating Post-Operative Pain
• China Aoxing Pharmaceutical Company Announces Successful Completion Of Phase II Clinical Study Of Novel Menstrual Pain Drug
• AcelRx Announces Perfect Performance Of Handheld Component Of ARX-01 Sufentanil NanoTab PCA System In A Phase 2 Study
• AcelRx Announces Positive Results From A Phase 2 Study Of ARX-03, A Sufentanil/Triazolam NanoTab For Procedural Sedation, Anxiolysis & Analgesia
• AcelRx Announces Initiation Of Phase 2 Cancer Breakthrough Pain Program
• New Pain Management Approaches Reduce Pain, Speed Recovery For Knee Or Hip Replacement
• Fear Of Prescription Drug Abuse Affects Pain Management
• Pain management failing as fears of prescription drug abuse rise
• New Drug Application Submitted To FDA For Tapentadol Extended Release Tablets For Management Of Chronic Pain
• FDA’s Woodcock Discusses Pain Management And Drug Safety In Nov. 26, 2009 Issue Of The New England Journal Of Medicine
• QRxPharma Initiates Pivotal Phase 3 Study Of MoxDuo(TM)IR For Moderate To Severe Acute Pain
• Brief Training In Meditation May Help In Pain Management
• Pacira’s Phase III Study Of EXPAREL(TM) Meets Primary Pain Relief Endpoint
• New Data Presented At ACR Meeting Demonstrates Colcrys(TM) (Colchicine, USP) Significantly Reduces Pain Of Acute Gout Flare Within 24 Hours
• Newly Published Clinical Data Shows Caldolor(R) (Ibuprofen) Injection Reduces Opioid Use While Improving Pain Relief In Post-Operative Patients

Tags: acelrx, completion, management, meeting, nanotab, operative, pain, phase, successful, sufentanil

This entry was posted on Thursday, November 5th, 2009 at 9:11 am and is filed under Analgesics Pain Migraine. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.